People In Brief
This article was originally published in The Gray Sheet
Edwards expands D.C. presence: Dirksen Lehman and Barry Liden are heading up Edwards Lifesciences' Washington, D.C., government affairs office, the firm announces Oct. 26. Lehman, the new VP-government affairs, joins Edwards from consulting firm Clark & Weinstock, where he led the health care practice. He previously served as special assistant to the President for legislative affairs as the White House's primary liaison to the Senate for health care issues (1"The Gray Sheet" Feb. 5, 2001, p. 24). Liden, director for government affairs, joined the firm in 2002. He previously was director of external communications and most recently directed the firm's state government affairs operations from the Irvine, Calif., headquarters. Edwards says the D.C. office will support the company's growing role in AdvaMed, of which CEO Michael Mussallem becomes chairman in 2008 (2"The Gray Sheet" March 12, 2007, In Brief)
You may also be interested in...
President Bush announces Jan. 30 his intention to name Senate Health Committee staff health counsel Lehman as a special assistant for legislative affairs for the Senate. Lehman will work as one of the Senate lobbyists in the White House Office of Legislative Affairs, reporting to chief Senate lobbyist Ziad Ojakli, former chief of staff to Sen. Paul Coverdell (R-Ga.). Before joining the Health Committee staff in 1999, Lehman was with Washington lobbying firm Williams & Jensen. The Health Committee has not yet named a replacement
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.